This new report provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
Geographic Coverage
France, Germany, Italy, Japan, Spain, UK, USAMarket Segmentation
Centralized Testing
- Hospitals
- Commercial/Private Laboratories
POC/Decentralized Testing
- Physician Offices/Group Practices
- Emergency Departments
- Ambulatory Care Centers
List of Tables
- France: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- Germany: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- Italy: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- Japan: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- Spain: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- UK: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
- USA: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment